Progress and Prospect in Intensive Care and Treatment of Patients with Solid Tumors
The incidence of cancer has remained high in recent years, and anti-tumor treatment methods are emerging. Cancer treatment has undergone significant changes, and the survival rate of patients with cancer has significantly improved. Various types of new anti-tumor treatments may not only treat and co...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Magazine House of Cancer Research on Prevention and Treatment
2023-12-01
|
| Series: | Zhongliu Fangzhi Yanjiu |
| Subjects: | |
| Online Access: | http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2023.23.0682 |
| _version_ | 1797372896285294592 |
|---|---|
| author | WANG Donghao |
| author_facet | WANG Donghao |
| author_sort | WANG Donghao |
| collection | DOAJ |
| description | The incidence of cancer has remained high in recent years, and anti-tumor treatment methods are emerging. Cancer treatment has undergone significant changes, and the survival rate of patients with cancer has significantly improved. Various types of new anti-tumor treatments may not only treat and control tumor growth but also place patients in critical situations that require treatment by intensive care medical personnel. Patients with cancer are in critical condition mainly due to three reasons: severe cases caused by cancer diseases themselves, complications during the perioperative period, and accompanying diseases and hospital acquired diseases. In the new situation, we should consider patient characteristics, such as abnormal metabolism, abnormal coagulation system, and abnormal immune mechanism, to save them from serious illness. We need to comprehensively evaluate patients with cancer, emphasize the role of the Intensive Care Unit (ICU) treatment platform, and promote the treatment concept of planned transfer to ICU, to improve the success rate and efficiency of treatment. After transferring the patient out of the ICU, the planned follow-up anti-tumor treatment can still be continued as the endpoint of ICU treatment for critically ill patients with cancer. In the future, efforts will be devoted to establishing a discipline and talent echelon with distinctive characteristics of oncology critical care medicine and treating "the critical illness of cancer and the cancer of critical illness". |
| first_indexed | 2024-03-08T18:42:27Z |
| format | Article |
| id | doaj.art-e9ddac2a518a4179b95950233809ac0a |
| institution | Directory Open Access Journal |
| issn | 1000-8578 |
| language | zho |
| last_indexed | 2024-03-08T18:42:27Z |
| publishDate | 2023-12-01 |
| publisher | Magazine House of Cancer Research on Prevention and Treatment |
| record_format | Article |
| series | Zhongliu Fangzhi Yanjiu |
| spelling | doaj.art-e9ddac2a518a4179b95950233809ac0a2023-12-29T06:02:13ZzhoMagazine House of Cancer Research on Prevention and TreatmentZhongliu Fangzhi Yanjiu1000-85782023-12-0150121149115210.3971/j.issn.1000-8578.2023.23.06828578.2023.23.0682Progress and Prospect in Intensive Care and Treatment of Patients with Solid TumorsWANG Donghao0Department of Intensive Care Unit, Tianjin Medical University Cancer Institute & Hospital, Tianjin 300060, ChinaThe incidence of cancer has remained high in recent years, and anti-tumor treatment methods are emerging. Cancer treatment has undergone significant changes, and the survival rate of patients with cancer has significantly improved. Various types of new anti-tumor treatments may not only treat and control tumor growth but also place patients in critical situations that require treatment by intensive care medical personnel. Patients with cancer are in critical condition mainly due to three reasons: severe cases caused by cancer diseases themselves, complications during the perioperative period, and accompanying diseases and hospital acquired diseases. In the new situation, we should consider patient characteristics, such as abnormal metabolism, abnormal coagulation system, and abnormal immune mechanism, to save them from serious illness. We need to comprehensively evaluate patients with cancer, emphasize the role of the Intensive Care Unit (ICU) treatment platform, and promote the treatment concept of planned transfer to ICU, to improve the success rate and efficiency of treatment. After transferring the patient out of the ICU, the planned follow-up anti-tumor treatment can still be continued as the endpoint of ICU treatment for critically ill patients with cancer. In the future, efforts will be devoted to establishing a discipline and talent echelon with distinctive characteristics of oncology critical care medicine and treating "the critical illness of cancer and the cancer of critical illness".http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2023.23.0682cancercritical patientsicutreatment |
| spellingShingle | WANG Donghao Progress and Prospect in Intensive Care and Treatment of Patients with Solid Tumors Zhongliu Fangzhi Yanjiu cancer critical patients icu treatment |
| title | Progress and Prospect in Intensive Care and Treatment of Patients with Solid Tumors |
| title_full | Progress and Prospect in Intensive Care and Treatment of Patients with Solid Tumors |
| title_fullStr | Progress and Prospect in Intensive Care and Treatment of Patients with Solid Tumors |
| title_full_unstemmed | Progress and Prospect in Intensive Care and Treatment of Patients with Solid Tumors |
| title_short | Progress and Prospect in Intensive Care and Treatment of Patients with Solid Tumors |
| title_sort | progress and prospect in intensive care and treatment of patients with solid tumors |
| topic | cancer critical patients icu treatment |
| url | http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2023.23.0682 |
| work_keys_str_mv | AT wangdonghao progressandprospectinintensivecareandtreatmentofpatientswithsolidtumors |